SARS-CoV-2 Infection and the Newborn

Area of Science:

• Pediatrics
• Infectious Diseases
• Neonatology

Background:

• Severe Acute Respiratory Syndrome Coronavirus Type 2 (SARS-CoV-2) affects all age groups, including pregnant women and newborns.
• Limited information exists on the clinical features, laboratory findings, and prognosis of SARS-CoV-2 in pediatric and neonatal populations.
• Pregnancy cases primarily occurred in the second or third trimester, with a low incidence of severe disease and rare miscarriages.

Purpose of the Study:

• To summarize the current knowledge on SARS-CoV-2 in pregnant women and newborns.
• To highlight diagnostic criteria and clinical manifestations.
• To outline management strategies and emphasize the need for continuous updates.

Main Methods:

• Review of reported cases and existing literature on SARS-CoV-2 in pregnant women and neonates.
• Analysis of diagnostic methods, including Polymerase Chain Reaction (PCR) testing.
• Description of clinical presentation, laboratory findings, and treatment approaches.

Main Results:

• Materno-fetal transmission of SARS-CoV-2 remains controversial.
• Potential findings include lymphopenia, liver, and renal dysfunction.
• No deaths have been reported in the neonatal population; supportive care is crucial.

Conclusions:

• Diagnosis relies on contact history, symptoms (fever, pneumonia, GI issues), and PCR testing.
• Neonates require isolation precautions, with symptomatic cases managed in NICU and asymptomatic infants at home.
• No specific treatment exists, but supportive care, hemodynamic stabilization, and respiratory management are vital. Psychological support for families and staff is recommended.